US Patent 7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin

Patent 7973151 was granted and assigned to Amgen on July, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7973151

Date of Patent

July 5, 2011

Patent Application Number

12723499

Date Filed

March 12, 2010

Patent Citations Received

‌

US Patent 12110324 Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

Patent Primary Examiner

‌

Prema Mertz

Patent abstract

Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API